4 Einträge gefunden

1. Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, MAIA

   1. Cavo, Michele
   2. San-Miguel, Jesus F F
   3. Usmani, Saad Z
   4. Weisel, Katja C
   5. Dimopoulos, Meletios A A
   6. Avet-Loiseau, Hervé
   7. Paiva, Bruno

   2022 - Forschungsinformationssystem des UKE
2. Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR

   1. Avet-Loiseau, Hervé
   2. San-Miguel, Jesus
   3. Casneuf, Tineke
   4. Iida, Shinsuke
   5. Lonial, Sagar
   6. Usmani, Saad Z
   7. Spencer, Andrew

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network

   1. Ludwig, Heinz
   2. Sonneveld, Pieter
   3. Facon, Thierry
   4. San-Miguel, Jesus
   5. Avet-Loiseau, Hervé
   6. Mohty, Mohamad
   7. Mateos, Maria-Victoria

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk

   1. Weisel, Katja
   2. Spencer, Andrew
   3. Lentzsch, Suzanne
   4. Avet-Loiseau, Hervé
   5. Mark, Tomer M
   6. Spicka, Ivan
   7. Masszi, Tamas

   2020 - Forschungsinformationssystem des UKE